We believe health data is underutilized. We use real-world patient data to enable personalized healthcare paths for our clients to improve their quality of life. Therefore, we develop digital biomarkers.
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data. They are collected and measured by means of digital devices such as portables, wearables, implantables or digestibles.
Clinical validated digital biomarkers provide objective data that provides clinically significant results. This enables decision support to clinicians and will optimize patients’ health paths.
Orikami develops digital solutions for remote home monitoring according to the highest quality standards of the European Medical Device Regulation (MDR). Earlier this year we started the certification process of our Quality Management System according to…
As of October 1, 2022, Bert Seegers is the new CEO of Orikami. Bert has contributed to the growth of Orikami over the past 5 years as Chief Business Officer. Orikami will be pursuing a…
